Antitumor Efficacy and Molecular Correlates of a Novel Tropolone Derivative JO-122(2) in Combination with Temozolomide in a U87MG Glioblastoma Xenograft Model

Kit,O , Maksimov,A , Golovinov,I , Kuznetsova,N , Kaplieva,I , Khodakova,D , Sagakyants,A , Galina,A , Shulga,A , Gurova,S , Bondarenko,E , Rostorguev,E , Sayapin,Y and Gusakov,E . (2024). Antitumor Efficacy and Molecular Correlates of a Novel Tropolone Derivative JO-122(2) in Combination with Temozolomide in a U87MG Glioblastoma Xenograft Model. (e739558). Iranian Biomedical Journal, 0(0), e739558 doi: 10.61882/ibj.5466

Kit,O , , Maksimov,A , , Golovinov,I , , Kuznetsova,N , , Kaplieva,I , , Khodakova,D , , Sagakyants,A , , Galina,A , , Shulga,A , , Gurova,S , , Bondarenko,E , , Rostorguev,E , , Sayapin,Y , and Gusakov,E . "Antitumor Efficacy and Molecular Correlates of a Novel Tropolone Derivative JO-122(2) in Combination with Temozolomide in a U87MG Glioblastoma Xenograft Model" .e739558 , Iranian Biomedical Journal, 0, 0, 2024, e739558. doi: 10.61882/ibj.5466

Kit O, Maksimov A, Golovinov I, Kuznetsova N, Kaplieva I, Khodakova D, Sagakyants A, Galina A, Shulga A, Gurova S, Bondarenko E, Rostorguev E, Sayapin Y, Gusakov E. (2024). 'Antitumor Efficacy and Molecular Correlates of a Novel Tropolone Derivative JO-122(2) in Combination with Temozolomide in a U87MG Glioblastoma Xenograft Model', Iranian Biomedical Journal, 0(0), e739558. doi: 10.61882/ibj.5466

O Kit, A Maksimov, I Golovinov, N Kuznetsova, I Kaplieva, D Khodakova, A Sagakyants, A Galina, A Shulga, S Gurova, E Bondarenko, E Rostorguev, Y Sayapin and E Gusakov, "Antitumor Efficacy and Molecular Correlates of a Novel Tropolone Derivative JO-122(2) in Combination with Temozolomide in a U87MG Glioblastoma Xenograft Model," Iranian Biomedical Journal, 0 0 (2024): e739558, doi: 10.61882/ibj.5466

Kit O, Maksimov A, Golovinov I, Kuznetsova N, Kaplieva I, Khodakova D, Sagakyants A, Galina A, Shulga A, Gurova S, Bondarenko E, Rostorguev E, Sayapin Y, Gusakov E. Antitumor Efficacy and Molecular Correlates of a Novel Tropolone Derivative JO-122(2) in Combination with Temozolomide in a U87MG Glioblastoma Xenograft Model. Iranian Biomedical Journal. 2024;0(0):e739558. doi: 10.61882/ibj.5466